Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)
Single-dose TQ for P. vivax malaria in Brazil's Amazon region was positively received by HCPs and patients. Positive perceptions of the medication may aid in improving patient adherence to malaria treatment, thereby reducing malaria recurrences. The findings underscore the importance of adaptive training to optimize P. vivax radical cure implementation.
Authors
- Alícia Cacau Santos (ORCID: https://orcid.org/0000-0002-5613-0467)
- Ana Oliveira (ORCID: https://orcid.org/0000-0003-4516-6904)
- Hiran Sátiro Souza da Gama
- Dhélio B. Pereira (ORCID: https://orcid.org/0000-0002-7761-5498)
- Marcelo Augusto Mota Brito (ORCID: https://orcid.org/0000-0001-9134-3970)
- Felipe Murta (ORCID: https://orcid.org/0000-0003-4414-3989)
- Evellyn Antonieta Rondon Tomé da Silva
- Cássio Peterka (ORCID: https://orcid.org/0000-0003-2184-5531)
- Rafaela Nunes Dávila (ORCID: https://orcid.org/0009-0003-8188-1881)
- Rosilene Rufatto
- Patrícia C. S. Balieiro
- Marcus V. G. Lacerda
- Penny Grewal Daumerie
- Hélio A. Amazonas
Institutions
- Fundação de Medicina Tropical (BR)
- Fundação de Amparo à Pesquisa do Estado do Amazonas (BR)
- Ministério da Saúde (BR)
- Universidade do Estado do Amazonas (BR)
- Fundação Oswaldo Cruz (BR)
- Medicines for Malaria Venture (CH)
- The University of Texas Medical Branch at Galveston (US)
- Companhia Energética de Minas Gerais (Brazil) (BR)
Publication Details
- Journal
- Malaria Journal
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1186/s12936-024-05209-1
- Citations
- 3
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Bill and Melinda Gates Foundation
- Newcrest Mining
- Government of the United Kingdom
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Medicines for Malaria Venture
- Fundação de Amparo à Pesquisa do Estado do Amazonas